Avanos Medical, Inc. provided earnings guidance for 2024. For the period, the company expects net sales to be between $685 and $705 million, which assumes organic growth between 3% to 6%, excluding the impact of the product portfolio rationalization under the Transformation Process.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.1 USD | +1.40% | -3.26% | -19.30% |
1st Jan change | Capi. | |
---|---|---|
-19.30% | 781M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- AVNS Stock
- News Avanos Medical, Inc.
- Avanos Medical, Inc. Provides Earnings Guidance for 2024